Archives for: April 21st, 2016

CorMedix to Present Data from Landmark Post-Approval Surveillance Study at National Kidney Foundation® 2016 Spring Clinical Meetings

Written by Welcome on April 21, 2016

Bedminster, NJ – April 21, 2016 – CorMedix Inc. (NYSE…

CorMedix Inc. to Present Post-Market Clinical Utility Data from Neutrolin® Usage Monitoring Program on May 23, 2016

Written by Welcome on April 12, 2016

Data to be Presented at the 53rd Joint Congress of…

CorMedix Proprietary Antimicrobial Technology Featured at the ASAPS Aesthetic Meeting 2016

Written by Welcome on April 8, 2016

Bedminster, NJ – April 8, 2016 – CorMedix Inc. (NYSE…

CorMedix Inc. to be Featured on Panel at FBR & Co. Healthcare Series Event Focused on Infectious Diseases

Written by Welcome on April 6, 2016

New Prescriptions: Innovation in the Treatment of Diseases and Infections…